Chemistry World reports Novo is buying rights to new weight loss and cardiometabolic drugs to offset expected revenue loss as semaglutide patents expire in Europe and the US.
Recap by typeshit. Full story at Chemistry World.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
UW Medicine breaks down the peptide therapies now showing up everywhere and what they are.
A 72-year-old patient says her side effects got far worse after her telehealth site switched compounders, as an estimated 5 million Americans now use compounded GLP-1s.
Loading…